GB0909213D0 - Compound - Google Patents

Compound

Info

Publication number
GB0909213D0
GB0909213D0 GBGB0909213.1A GB0909213A GB0909213D0 GB 0909213 D0 GB0909213 D0 GB 0909213D0 GB 0909213 A GB0909213 A GB 0909213A GB 0909213 D0 GB0909213 D0 GB 0909213D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0909213.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aston University
Original Assignee
Aston University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aston University filed Critical Aston University
Priority to GBGB0909213.1A priority Critical patent/GB0909213D0/en
Publication of GB0909213D0 publication Critical patent/GB0909213D0/en
Priority to PCT/GB2010/050879 priority patent/WO2010136804A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0909213.1A 2009-05-28 2009-05-28 Compound Ceased GB0909213D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0909213.1A GB0909213D0 (en) 2009-05-28 2009-05-28 Compound
PCT/GB2010/050879 WO2010136804A1 (en) 2009-05-28 2010-05-27 Pyrimidine derivatives for use as antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0909213.1A GB0909213D0 (en) 2009-05-28 2009-05-28 Compound

Publications (1)

Publication Number Publication Date
GB0909213D0 true GB0909213D0 (en) 2009-07-15

Family

ID=40902258

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0909213.1A Ceased GB0909213D0 (en) 2009-05-28 2009-05-28 Compound

Country Status (2)

Country Link
GB (1) GB0909213D0 (en)
WO (1) WO2010136804A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10316371B2 (en) * 2011-03-29 2019-06-11 Trana Discovery, Inc. Screening methods for identifying specific Staphylococcus aureus inhibitors
WO2016032127A2 (en) * 2014-08-25 2016-03-03 부산대학교 산학협력단 Novel compounds having antioxidant and anti-inflammatory activities due to competition with lps for binding to tlr4, and medical use thereof
RU2572081C1 (en) * 2014-09-09 2015-12-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Астраханский государственный университет" Method of obtaining 5-(arylmethylene)hexahydropyrimidine-2,4,6-triones
EP4219458A3 (en) 2017-08-31 2023-10-18 Bar Ilan University Novel barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer
CN111233839B (en) * 2020-02-26 2021-06-15 陕西科技大学 (E) 1-Acyl-2-(2-(9-alkyl)carbazole-3-)vinyl-benzimidazole and its preparation method
WO2022245120A1 (en) * 2021-05-18 2022-11-24 부산대학교 산학협력단 Novel compound and composition containing same as active ingredient for inhibiting biofilm formation or virulence of pathogenic microorganism
KR102858576B1 (en) * 2021-05-18 2025-09-12 부산대학교 산학협력단 Novel compound and composition for inhibiting biofilm formation or virulence of pathogenic bacteria comprising the same as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126222A (en) * 1989-06-12 1992-06-30 Canon Kabushiki Kaisha Electrophotographic photosensitive member containing a barbituric acid or thiobarbituric acid derivative
GB2386892A (en) * 2002-03-28 2003-10-01 Pantherix Ltd Carboxy containing (phenyl-/heterocyclyl-)methylene substituted azole & azine derivatives and their therapeutic use as antibacterials
WO2005076695A2 (en) * 2004-02-11 2005-08-25 Painceptor Pharma Corporation Methods of modulating neurotrophin-mediated activity
CN1721413A (en) * 2004-07-15 2006-01-18 中国科学院上海药物研究所 A class of barbituric acid compounds, its preparation method and application

Also Published As

Publication number Publication date
WO2010136804A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
EP2423182A4 (en) Diacylethylenediamine compound
GB0907425D0 (en) Compounds
EP2393493A4 (en) Compounds
GB0903759D0 (en) Compound
GB0907515D0 (en) Compounds
GB0919194D0 (en) Compounds
GB0915892D0 (en) Compounds
GB0914767D0 (en) Compound
GB0905641D0 (en) Compounds
GB0909671D0 (en) Compounds
GB0909213D0 (en) Compound
EP2487178A4 (en) Pyrazolothiazole compound
GB0909672D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0914883D0 (en) Compound
EP2443115A4 (en) Compounds
GB0922003D0 (en) Compound
GB0917460D0 (en) Compound
GB0901976D0 (en) Compound
GB0906821D0 (en) Compound
GB0916603D0 (en) Compound
GB0922714D0 (en) Compound
GB0910692D0 (en) Compound
GB0907825D0 (en) Novel compound
GB0904746D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)